Update Information
Latest Update
This resource was last updated on: 2025-7-10
New topics:
- arimoclomol
- axatilimab
- cantharidin
- crovalimab
- elafibranor
- ensartinib
- eplontersen
- landiolol
- letibotulinumtoxinA
Changed topics:
- abacavir
- abrocitinib
- acetaminophen
- adalimumab
- adefovir
- aliskiren
- alosetron
- ALPRAZolam
- alprostadil (systemic)
- alvimopan
- aMILoride
- amiodarone
- amoxapine
- amphetamine mixtures
- AMPHOTERICIN B
- ampicillin/sulbactam
- apomorphine
- aprocitentan
- arsenic trioxide
- asenapine
- atenolol
- atomoxetine
- auranofin
- azaTHIOprine
- azilsartan
- baclofen
- baricitinib
- bedaquiline
- bempedoic acid
- benazepril
- bexarotene
- bictegravir/emtricitabine/tenofovir alafenamide
- bleomycin
- bosentan
- brexpiprazole
- bumetanide
- BUPivacaine
- buprenorphine
- buPROPion
- busulfan
- butalbital, acetaminophen†
- butalbital, acetaminophen, caffeine†
- butorphanol
- cabazitaxel
- calcium oxybate/magnesium oxybate/potassium oxybate/sodium oxybate
- candesartan
- capecitabine
- captopril
- CARBOplatin
- carboprost
- cariprazine
- carmustine
- celecoxib
- chlorambucil
- chloramphenicol
- chlordiazePOXIDE
- chlorproMAZINE
- cidofovir
- cilostazol
- ciprofloxacin
- CISplatin
- citalopram
- cladribine
- clindamycin
- cloBAZam
- clomiPRAMINE
- clonazePAM
- cloNIDine
- clopidogrel
- clorazepate
- codeine
- cycloSPORINE
- cytarabine
- dabigatran
- dacarbazine
- dalteparin
- danazol
- dantrolene
- darunavir/cobicistat/emtricitabine/tenofovir alafenamide
- daunorubicin/cytarabine liposomal
- DAUNOrubicin hydrochloride
- deferasirox
- deferiprone
- delafloxacin
- desmopressin
- desvenlafaxine
- deutetrabenazine
- dexmethylphenidate
- DICLOFENAC
- DOCEtaxel
- dofetilide
- dolutegravir/lamivudine
- doravirine/lamivudine/tenofovir disoproxil fumarate
- DOXOrubicin hydrochloride
- doxylamine/pyridoxine
- DULoxetine
- edaravone
- edoxaban
- eflornithine (systemic)
- elagolix/estradiol/norethindrone
- elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
- encorafenib
- entacapone
- entecavir
- enzalutamide
- eplerenone
- epoetin alfa
- epoprostenol
- eptifibatide
- erlotinib
- ertapenem
- escitalopram
- esketamine
- esomeprazole
- ESTRADIOL
- estrogens, conjugated
- eszopiclone
- ethambutol
- etrasimod
- everolimus
- exemestane
- ezetimibe
- famciclovir
- famotidine
- febuxostat
- fentaNYL (parenteral)
- fentaNYL (transdermal)
- ferrous sulfate (30% elemental iron)
- fesoterodine
- fexofenadine
- finasteride
- finerenone
- flibanserin
- fludrocortisone
- flumazenil
- FLUoxetine
- fluvoxaMINE
- fondaparinux
- foscarnet
- fosphenytoin
- ganciclovir
- glatiramer
- HYDROcodone
- HYDROmorphone
- lamiVUDine
- leflunomide
- levothyroxine
- linaCLOtide
- macitentan
- medroxyPROGESTERone†
- meperidine
- metFORMIN
- methadone
- methotrexate
- METHYLPHENIDATE
- metroNIDAZOLE
- midazolam
- midodrine
- morphine
- mycophenolate mofetil
- nalbuphine
- NITROGLYCERIN
- oxyCODONE
- phenelzine
- prochlorperazine
- progesterone
- sacubitril/valsartan
- sirolimus (conventional)
- tapentadol
Citation
Vallerand, April Hazard., et al. "Update Information." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50998/all/___Update_Information___.
Vallerand AHA, Sanoski CAC, . Update Information. Davis's Drug Guide. F.A. Davis Company; 2025. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50998/all/___Update_Information___. Accessed July 16, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Update Information. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50998/all/___Update_Information___
Vallerand AHA, Sanoski CAC, . Update Information [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 July 16]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50998/all/___Update_Information___.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Update Information
ID - 50998
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50998/all/___Update_Information___
PB - F.A. Davis Company
ET - 19
DB - Nursing Central
DP - Unbound Medicine
ER -